Daejeon, South Korea

Eun Seo Jang

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Peptron, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eun Seo Jang. Retrieved from https://idiyas.com/inventor/eun-seo-jang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eun Seo Jang: Patent Inventor in Daejeon

Introduction

Eun Seo Jang is an inventor based in Daejeon, South Korea. Her patent work includes a pharmaceutical formulation designed for the sustained release of semaglutide.

Latest Patents

Jang is named on one patent: “Sustained Release Formulation Composition Comprising Semaglutide or Pharmaceutically Acceptable Salt Thereof.” The invention concerns a formulation intended to release semaglutide over an extended period.

Career Highlights

Jang is associated with Peptron, Inc., a company involved in pharmaceutical research and development. Her patent record reflects work on drug-delivery formulation technology. 1 patent

Collaborations

Jang’s listed coworkers include Ji Hyang Lee and Seung Gu Chang.

Conclusion

Eun Seo Jang’s patent activity in Daejeon centers on sustained-release semaglutide formulation technology and her association with Peptron, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…